Paper Details
- Home
- Paper Details
The effect of a once-daily oral dose of nadolol on intraocular pressure in normal volunteers.
Author: RennieI G, SmerdonD L
Original Abstract of the Article :
We compared the effects of once-daily oral administration of 20 mg and 40 mg of nadolol vs placebo in 40 normal volunteers in a randomized, double-masked trial. Each of 23 women and 17 men (ranging in age from 18 to 50 years) had intraocular pressure, pulse rate, blood pressure, pupil size, amplitud...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1016/0002-9394(85)90511-2
データ提供:米国国立医学図書館(NLM)
Nadolol: A Desert Oasis for Intraocular Pressure
Glaucoma, a condition that affects the eye's pressure, can feel like navigating a treacherous desert, where the threat of vision loss looms large. This study explores the potential of nadolol, a beta-blocker medication often used to treat high blood pressure, as a treatment for glaucoma, seeking to find a safe and effective oasis in this challenging landscape.
Nadolol: A Refreshing Oasis in the Desert of Glaucoma
The study reveals that nadolol, when administered orally, demonstrates a significant decrease in intraocular pressure, a welcome discovery akin to finding a hidden spring of relief in the desert. This effect, observed at both 20mg and 40mg doses, provides a glimmer of hope for individuals seeking to manage their glaucoma effectively.
Navigating the Desert of Glaucoma: A New Path
This study offers a new perspective on glaucoma management, highlighting the potential of nadolol as a valuable tool for controlling intraocular pressure. The findings encourage further exploration and investigation, seeking to understand the long-term effects and optimize the use of nadolol in treating this complex condition.
Dr.Camel's Conclusion
The desert of glaucoma can be a daunting place, where the risk of vision loss casts a long shadow. This study unveils a potential oasis in the form of nadolol, offering a glimmer of hope for individuals seeking to manage this challenging condition. The findings encourage us to explore new pathways in treating this complex disease, seeking innovative solutions that can create a more peaceful and comfortable journey through this challenging landscape.
Date :
- Date Completed 1985-10-21
- Date Revised 2019-06-27
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.